12 February 2019

Decision GIF no. 12/WS/2019; 13/WS/2019; 14/WS/2019 of 11.02.2019

Poprzedni Następny

On 11.02.2019, the Chief Pharmaceutical Inspector issued a decision to temporarily prohibit placing on the market and withhold the trade of all medicinal products containing the active substance fenspiride hydrochloride (Fenspiridi hydrochloridum) across the country, this including:

• Pulneo (Fenspiridi hydrochloridum) oral drops, solution 15 ml and 30 ml;
• Pulneo (Fenspiridi hydrochloridum) cola-flavored syrup 150 ml;
• Pulneo (Fenspiridi hydrochloridum) syrup 150 ml.

The above applies until the end of the explanatory procedure.

News

23 August 2023

Over six and a half million for Ukraine!

We couldn’t be prouder to say that since the outbreak of war in Ukraine Pabianice-based Aflofarm Farmacja Polska has made continued efforts to provide humanitarian support.
And again, we gladly donated aid of nearly 2m PLN, the overall aid totalling 6.5m PLN in the ballpark figure!

30 June 2023

Aflofarm voted top family business for the consecutive year in the Family Business Ranking by Forbes!

The extraordinary winning streak continues into 2022. We are delighted to announce that Aflofarm Farmacja Polska ranked first in the Family Business Ranking by Forbes in the category of businesses with revenue over 100 million PLN. Aflofarm scooped up the revered title of the best family business once again, making this the fourth year of achievement in the truly extraordinary winning streak.

21 June 2023

Recognised by Wprost Magazine ranking, awarded with Gepard Biznesu title

We have been again recognised by Wprost Magazine as Poland’s biggest company established with the Polish capital, one of those who managed to go through war crisis and economic turmoil with the upper hand, while successfully able to maintain continuous growth and development trend. When it comes to pharma business - we have been awarded the title of ‘Gepard Biznesu 2022’ - for the revenue growth dynamics and reported net earnings figure.

All news